Logo image of CRBD

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CRBD - US21871X2080

23.74 USD
+0.12 (+0.51%)
Last: 11/26/2025, 8:24:28 PM
Fundamental Rating

4

Overall CRBD gets a fundamental rating of 4 out of 10. We evaluated CRBD against 98 industry peers in the Financial Services industry. There are concerns on the financial health of CRBD while its profitability can be described as average. CRBD scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CRBD was profitable.
In the past year CRBD had a positive cash flow from operations.
CRBD had positive earnings in each of the past 5 years.
In the past 5 years CRBD always reported a positive cash flow from operatings.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

CRBD has a worse Return On Assets (0.24%) than 68.37% of its industry peers.
The Return On Equity of CRBD (7.32%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROIC N/A
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

Looking at the Profit Margin, with a value of 5.64%, CRBD is in line with its industry, outperforming 42.86% of the companies in the same industry.
CRBD's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 12.90%, CRBD perfoms like the industry average, outperforming 47.96% of the companies in the same industry.
CRBD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.9%
PM (TTM) 5.64%
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

CRBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRBD has been reduced compared to 1 year ago.
Compared to 5 years ago, CRBD has less shares outstanding
Compared to 1 year ago, CRBD has a worse debt to assets ratio.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

The Debt to FCF ratio of CRBD is 6.80, which is on the high side as it means it would take CRBD, 6.80 years of fcf income to pay off all of its debts.
CRBD has a Debt to FCF ratio (6.80) which is comparable to the rest of the industry.
CRBD has a Debt/Equity ratio of 0.81. This is a neutral value indicating CRBD is somewhat dependend on debt financing.
CRBD has a Debt to Equity ratio (0.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Altman-Z N/A
ROIC/WACCN/A
WACC6.08%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CRBD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.29%.
Measured over the past years, CRBD shows a very strong growth in Earnings Per Share. The EPS has been growing by 115.54% on average per year.
CRBD shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.58%.
The Revenue has been growing by 8.01% on average over the past years. This is quite good.
EPS 1Y (TTM)1.29%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%-30.43%
Revenue 1Y (TTM)20.58%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%24.11%

3.2 Future

CRBD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.31% yearly.
CRBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.89% yearly.
EPS Next Y-2.56%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
EPS Next 5Y8.31%
Revenue Next Year-10.4%
Revenue Next 2Y-2.8%
Revenue Next 3Y0.65%
Revenue Next 5Y2.89%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.04, which indicates a rather cheap valuation of CRBD.
CRBD's Price/Earnings ratio is rather cheap when compared to the industry. CRBD is cheaper than 93.88% of the companies in the same industry.
When comparing the Price/Earnings ratio of CRBD to the average of the S&P500 Index (26.15), we can say CRBD is valued rather cheaply.
With a Price/Forward Earnings ratio of 4.23, the valuation of CRBD can be described as very cheap.
93.88% of the companies in the same industry are more expensive than CRBD, based on the Price/Forward Earnings ratio.
CRBD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.12.
Industry RankSector Rank
PE 5.04
Fwd PE 4.23
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CRBD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBD is cheaper than 73.47% of the companies in the same industry.
CRBD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBD is cheaper than 83.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.63
EV/EBITDA 8.5
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.04
EPS Next 2Y7.69%
EPS Next 3Y11.02%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.46%, CRBD has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.20, CRBD pays a bit more dividend than its industry peers.
CRBD's Dividend Yield is a higher than the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.46%

5.2 History

CRBD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CRBD pays out 52.57% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP52.57%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
CRBD Dividend Payout.CRBD Dividend Payout, showing the Payout Ratio.CRBD Dividend Payout.PayoutRetained Earnings

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (11/26/2025, 8:24:28 PM)

23.74

+0.12 (+0.51%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners86.58%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap12.36B
Revenue(TTM)17.58B
Net Income(TTM)991.00M
Analysts79.05
Price Target34.2 (44.06%)
Short Float %0.01%
Short Ratio1.03
Dividend
Industry RankSector Rank
Dividend Yield 3.46%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP52.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.09%
Min EPS beat(2)-9.38%
Max EPS beat(2)15.55%
EPS beat(4)2
Avg EPS beat(4)1.6%
Min EPS beat(4)-9.38%
Max EPS beat(4)15.55%
EPS beat(8)6
Avg EPS beat(8)3.78%
EPS beat(12)9
Avg EPS beat(12)6.23%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-11.42%
Max Revenue beat(2)9.43%
Revenue beat(4)1
Avg Revenue beat(4)-7.19%
Min Revenue beat(4)-14.87%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-15.26%
Revenue beat(12)4
Avg Revenue beat(12)-10.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8%
PT rev (3m)17.33%
EPS NQ rev (1m)-2.72%
EPS NQ rev (3m)-8.93%
EPS NY rev (1m)-4.1%
EPS NY rev (3m)-4.75%
Revenue NQ rev (1m)5.13%
Revenue NQ rev (3m)5.66%
Revenue NY rev (1m)-1.41%
Revenue NY rev (3m)-7.61%
Valuation
Industry RankSector Rank
PE 5.04
Fwd PE 4.23
P/S 0.7
P/FCF 7.63
P/OCF 7.63
P/B 0.91
P/tB 0.91
EV/EBITDA 8.5
EPS(TTM)4.71
EY19.84%
EPS(NY)5.61
Fwd EY23.64%
FCF(TTM)3.11
FCFY13.1%
OCF(TTM)3.11
OCFY13.1%
SpS33.78
BVpS26.02
TBVpS26.02
PEG (NY)N/A
PEG (5Y)0.04
Graham Number52.51
Profitability
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.9%
PM (TTM) 5.64%
GM N/A
FCFM 9.21%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Debt/EBITDA 4.06
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.58
Cash Conversion 59.72%
Profit Quality 163.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC6.08%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)1.29%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%-30.43%
EPS Next Y-2.56%
EPS Next 2Y7.69%
EPS Next 3Y11.02%
EPS Next 5Y8.31%
Revenue 1Y (TTM)20.58%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%24.11%
Revenue Next Year-10.4%
Revenue Next 2Y-2.8%
Revenue Next 3Y0.65%
Revenue Next 5Y2.89%
EBIT growth 1Y291.07%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-5.93%
EBIT Next 3Y-0.33%
EBIT Next 5YN/A
FCF growth 1Y-47.72%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-47.72%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 / CRBD FAQ

Can you provide the ChartMill fundamental rating for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a fundamental rating of 4 / 10 to CRBD.


Can you provide the valuation status for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a valuation rating of 7 / 10 to COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD). This can be considered as Undervalued.


How profitable is COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CRBD stock?

The Earnings per Share (EPS) of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is expected to decline by -2.56% in the next year.


How sustainable is the dividend of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

The dividend rating of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 3 / 10 and the dividend payout ratio is 52.57%.